Perry Scanlan

Dr. Scanlan is a Professor and Program Director for the Medical Laboratory Science at Austin Peay State University. He received his Bachelor of Science in Clinical Laboratory Science and Medical Microbiology and Immunology from the University of Wisconsin - Madison in 2000. He received his Ph.D. from the University of Illinois at Chicago in 2006 in Microbiology and Immunology. Dr. Scanlan's doctoral thesis focused on the role of glycoprotein gH on Herpes Simplex Virus entry mechanisms.

Dr. Scanlan's current research interests are in the area of infection control and infectious disease tracking in medical facilities. Additionally, Dr. Scanlan also publishes on topics related to Medical Laboratory Science workforce issues.

Scanlan PM, Hu P. 2014-2015 Clinical Laboratory Science Faculty Salary Survey. Clinical Laboratory Science. 29(2).

Ameigh RA, Semler JR, Lebkuecher AL, Scanlan PM. Managing Tuberculosis: An Interdisciplinary Perspective. Clinical Laboratory Science. 28(1).

Scanlan PM. A Review of Bachelor's Degree Medical Laboratory Science Education and Entry Level Practice in the United States. 2013. International Federation of Clinical Chemistry and Laboratory Medicine. 24(1):1-9.

Scanlan PM. Letter to the editor RE: American Society for Clinical Pathology's 2011 Vacancy Survey of U.S. Clinical Laboratories. 2011. Lab Med. July; 42(7):442.

Scanlan PM. Alphaherpesviruses. Continuing Education Module, Colorado Association for Continuing Medical Laboratory Education (CACMLE) July 2011.

Scanlan PM. Powerpoint Online Teaching Resources (All 41 Chapters and 31 Case Studies), Textbook of Diagnostic Microbiology 4th ed. July 2009. Elsevier Science, Philadelphia, PA.

Valyi-Nagy T., Shukla D., Engelhard HH, Scanlan PM. Latency Strategies of Alphaherpesviruses: Herpes simplex viruses and Varicella- Zoster Virus Latency in Neurons. 2006. In Latency strategies of herpesviruses. Minarovits J (ed), Springer, New York.

Clement C, Tiwari V, Scanlan PM, Valyi-Nagy T, Yue BY, Shukla D. 2006. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol. Sep 25;174(7):1009-21.

Shukla D, Scanlan PM, Tiwari V, Sheth V, Clement C, Guzman-Hartman G, Dermody TS, Valyi-Nagy T. 2006. Expression of nectin-1 in normal and herpes simplex virus type 1-infected murine brain. Appl Immunohistochem Mol Morphol. Sep;14(3):341-7.

Scanlan PM, Tiwari V, Bommireddy S, Shukla D. 2005. Spinoculation of heparan sulfate deficient cells enhances HSV-1 entry, but does not abolish the need for essential glycoproteins in viral fusion. J Virol Methods. Sep;128(1-2):104-12.

Tiwari V, Clement C, Scanlan PM, Kowlessur D, Yue BY, Shukla D. 2005. A role for herpesvirus entry mediator as the receptor for herpes simplex virus 1 entry into primary human trabecular meshwork cells. J Virol. 2005 Oct;79(20):13173-9.

Valyi-Nagy T, Sheth V, Clement C, Tiwari V, Scanlan P, Kavouras JH, Leach L, Guzman-Hartman G, Dermody TS, Shukla D. 2004. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye. Curr Eye Res. Oct- Nov;29(4-5):303-9.

Scanlan PM., Tiwari V., Bommireddy S., Shukla D. 2003. Cellular Expression of gH Confers Resistance to Herpes Simplex Virus Type-1 Entry. Virology. Jul 20;312(1):14-24.